Last10K.com

22Nd Century Group, Inc. (XXII) SEC Filing 10-K Annual report for the fiscal year ending Thursday, December 31, 2020

22Nd Century Group, Inc.

HISTORY TOOLS
CIK: 1347858 Ticker: XXII

Exhibit 99.1

​

22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2020

​

Key Business and Financial Highlights

​

●22nd Century has a tremendous global commercial opportunity in the more than $800 billion markets across the tobacco and hemp/cannabis industry.
●Securing Modified Risk Tobacco Product (MRTP) authorization for VLN® remains 22nd Century’s number one priority. The Company is highly confident that the FDA is in the final stages of the review process related to its application.
●22nd Century is fully prepared and eager to launch VLN® King and VLN® Menthol King within 90 days of receiving MRTP designation. MRTP designation is a catalyst for the VLN® brand and tobacco franchise via partnerships and licensing agreements in the U.S. and internationally.
●22nd Century believes that recent political changes will likely be highly favorable to its business prospects from a policy priority and regulatory standpoint. The Company believes that, under the new administration, the FDA will now be re-energized in implementing its ground-breaking Comprehensive Plan for Tobacco and Nicotine Regulation, in particular the Agency’s plan to cap the amount of nicotine in combustible cigarettes to a “minimally or non-addictive” level.
●The Company has now secured four out of the five key partnerships needed to maximize each component in the upstream segment of the hemp/cannabis value chain. The partnerships will enable 22nd Century to accelerate the new development of valuable, commercial hemp/cannabis lines and intellectual property to market in two years while it monetizes a portion of the Company’s current portfolio of intellectual property (IP) from its previous license agreement with Anandia Laboratories. 22nd Century is also in final discussions with top-tier plant breeders that will be announced soon.
●Net sales revenue of $7.3 million for the fourth quarter was consistent over the prior-year period and improved by 8.8% to $28.1 million for the full-year.
●Gross profit for the fourth quarter improved by $364 thousand and by $1.4 million for the full-year; gross profit margin improved by 500 basis points for both periods.
●Net loss increased by $207 thousand for the fourth quarter. For the full-year, net loss improved by $6.8 million.
●Adjusted EBITDA was unfavorable by $1.3 million for the fourth quarter. For the full-year Adjusted EBITDA improved by $1.8 million.
●The Company’s balance sheet is well funded with $22.3 million at the end of full-year 2020. Additional cash of $11.8 million received from warrants exercised in February and March 2021 will provide the Company with additional runway to fuel current operations, strategy, and growth initiatives. 22nd Century does not have any outstanding warrants following these transactions.

​

Note: All financials referenced in this release are in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) and comparisons in this release are to the same period in the prior year unless otherwise noted.

​

WILLIAMSVILLE, N.Y., March 11, 2021 (Globe Newswire)

— 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that the Company filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission. The Company will provide a business update for investors on a live audio webcast to be held today at 8:00 a.m. ET.

​

James A. Mish, chief executive officer of 22nd Century Group, together with Michael Zercher, president and chief operating officer, and John Franzino, chief financial officer, will host the webcast. Interested parties are invited to participate by visiting the Events section on the Company’s Investor Relations website at www.xxiicentury.com/investors/events. Following prepared remarks, the Company will host a Q&A session during which management will accept questions from industry analysts. Investors, shareholders, and members of the media will also have the opportunity to submit their questions through the interactive webcast.

​

“Since joining 22nd Century Group in June, we have communicated our strategic plan and go forth strategy. Our stock price has increased significantly since reporting third quarter earnings demonstrating our commitment to our shareholders,” said James A. Mish, chief executive officer of 22nd Century Group. “As we look to 2021, we see tremendous commercial opportunity for our tobacco and hemp/cannabis franchises. Our focus remains on our primary mission: to reduce the harm caused by smoking. Once we secure MRTP designation, we will capitalize on our VLN® brand and begin to build our tobacco franchise through licensing and partnership opportunities in the U.S. and internationally. We have made significant progress in our hemp/cannabis research and look forward to monetizing a portion of our hemp/cannabis IP this year. With the majority of our hemp/cannabis operational partnerships now in place, we believe we will be able to commercialize our new disruptive, commercially valuable hemp/cannabis plants in development in two years.”

The following information was filed by 22Nd Century Group, Inc. (XXII) on Thursday, March 11, 2021 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate 22Nd Century Group, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by 22Nd Century Group, Inc..

Continue

Assess how 22Nd Century Group, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

22Nd Century Group, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
M & A
Revenue
Legal
Other
Filter Subcategory:
All
Expense
Shares
Cash Flow
Income
Earnings
Product
Debt
Other
Inside 22Nd Century Group, Inc.'s 10-K Annual Report:

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Shareholders' Equity
Consolidated Statements Of Operations And Comprehensive Loss
Commitments &Amp; Contingencies (Tables)
Commitments And Contingencies
Commitments And Contingencies - Investment, Mrtp, Litigation (Details)
Commitments And Contingencies - Licenses (Details)
Earnings Per Share
Earnings Per Share (Details)
Earnings Per Share (Tables)
Earnings Per Share - Anti-Dilutive Securities (Details)
Equity Based Compensation - Fair Value Assumptions (Details)
Equity- Based Compensation
Equity- Based Compensation (Tables)
Equity- Based Compensation - Rsus (Details)
Equity- Based Compensation - Stock Option Activity (Details)
Equity-Based Compensation (Details)
Equity-Based Compensation - Compensation Expense And Unrecognized Compensation (Details)
Fair Value Measurements - Available-For-Sale Securities (Details)
Fair Value Measurements - Changes In Fair Value, Level 3 (Details)
Fair Value Measurements - Maturity Of Available-For-Sale Securities By Contractual Maturity (Details)
Fair Value Measurements - Recurring (Details)
Fair Value Measurements And Short-Term Investments
Fair Value Measurements And Short-Term Investments (Tables)
Income Taxes
Income Taxes (Tables)
Income Taxes - Deferred Tax Assets And Liabilities (Details)
Income Taxes - Nols, Unrecognized (Details)
Income Taxes - Provision (Details)
Income Taxes - Rate Reconciliation (Details)
Intangible Assets
Intangible Assets (Details)
Intangible Assets (Tables)
Inventory
Inventory (Details)
Inventory (Tables)
Investments And Convertible Note Receivable
Investments And Convertible Note Receivable (Tables)
Investments And Convertible Note Receivable - Investment In Anandia (Details)
Investments And Convertible Note Receivable - Investment In Panacea (Details)
Investments And Convertible Note Receivable - Stock Split And Carrying Value (Details)
Machinery And Equipment
Machinery And Equipment (Details)
Machinery And Equipment (Tables)
Nature Of Business And Summary Of Significant Accounting Policies
Nature Of Business And Summary Of Significant Accounting Policies (Details)
Nature Of Business And Summary Of Significant Accounting Policies (Policies)
Nature Of Business And Summary Of Significant Accounting Policies - Machinery And Equipment (Details)
Notes Payable For License Fees
Notes Payable For License Fees (Details)
Notes Payable For License Fees (Tables)
Retirement Plan
Retirement Plan (Details)
Revenue Recognition
Revenue Recognition (Details)
Revenue Recognition (Tables)
Right-Of-Use Assets, Lease Obligations And Other Leases (Details)
Right-Of-Use Assets, Lease Obligations And Other Leases (Tables)
Right-Of-Use Assets, Lease Obligations, And Other Leases
Selected Quarterly Financial Data (Unaudited)
Selected Quarterly Financial Data (Unaudited) (Details)
Selected Quarterly Financial Data (Unaudited) (Tables)
Severance Liability
Severance Liability (Details)
Subsequent Event
Subsequent Event (Details)
Subsequent Event (Tables)
Warrants For Common Stock
Warrants For Common Stock (Details)
Warrants For Common Stock (Tables)
Warrants For Common Stock - Warrant Activity (Details)
Ticker: XXII
CIK: 1347858
Form Type: 10-K Annual Report
Accession Number: 0001558370-21-002771
Submitted to the SEC: Thu Mar 11 2021 8:36:14 AM EST
Accepted by the SEC: Thu Mar 11 2021
Period: Thursday, December 31, 2020
Industry: Cigarettes

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/xxii/0001558370-21-002771.htm